Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapita Regulatory News (CPI)

Share Price Information for Capita (CPI)

Share Price is delayed by 15 minutes
Get Live Data
368.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.50 (0.407%)
Market Cap: £440.79m
CPI Live PriceLast checked at - London Stock Exchange

Intraday Capita Share Chart

Capita approved for NHS Support Services Framework

6 Feb 2015 07:00

Capita plc - Capita approved for NHS Support Services Framework

Capita plc - Capita approved for NHS Support Services Framework

PR Newswire

London, February 5

Capita approved for NHS England's £3-5bn Lead Provider Framework for Commissioning Support Services Capita plc (`Capita') announced today that it has been approved by NHS Englandto join the new Lead Provider Framework for Commissioning Support Services.Clinical Commissioning Groups (CCGs) will be required to re-procure many oftheir support services by April 2016 in order to comply with EU procurementlaw, which NHS England anticipates will mean that between £3-5bn of serviceswill be procured through the framework. NHS England has put in place free procurement and legal support to reduce theburden on CCGs so that this process is as quick and simple as possible. Itexpects that the typical procurement process will only take three months toaward each contract. Capita and its supply chain partners, alongside only two other private sectorconsortia and nine NHS Commissioning Support Units and their partners, havebeen approved for the framework following a rigorous selection process. Capitahas been approved for the core Lot 1, `End-to-End Commissioning SupportServices', and for Lot 2A, `Specialist Decision Support Services - MedicinesManagement and Optimisation'. Lot 1 comprises a wide range of support services, such as back office financeand HR, GP IT services, contracting, engagement and business intelligence. Lot2A includes services for commissioners to support medicines procurement, theimplementation of new national guidance and analysis of data to identifyefficiencies in medicine use. Andy Parker, Capita's chief executive officer, said: "Our approval to join thisframework is a testament to Capita's experience in the health sector and widerpublic sector. The breadth and scale of services that will be procured throughthe new framework will transform service commissioning for the NHS and otherhealthcare providers. Capita's experience and breadth of support servicesposition us strongly to secure contracts and deliver services that will provideeffective support to CCGs. We are committed to supporting the NHS in enhancingits efficiency and delivering the best experience and care for patients." The framework will also be available to other public sector organisations, bothwithin the NHS and outside, including local authorities, who want to procuresome or all of their support services. ENDS Further details of the Lead Provider Framework can be found on the NHS Englandwebsite: http://www.england.nhs.uk/lpf/2015/02/05/lpf-launch/ Capita have a subcontracted supply chain of partners, including a number ofsmall to medium-sized enterprises or third sector organisations. For further information: Capita plc Tel: 020 7799 1525Andy Parker, Chief ExecutiveShona Nichols, Corporate Communications Director Media enquiries only: David HendyTel: 020 7654 2137 or 020 7654 2399 (out of hours)Email: david.hendy@capita.co.uk Kirsty SewterTel: 020 7654 2386 or 020 7654 2399 (out of hours)Email: kirsty.sewter@capita.co.uk Notes to editors Capita plc is the UK's leading provider of BPO and integrated professionalsupport service solutions. With 64,000 people at over 400 sites, including 73business centres across the UK, Europe, India and South Africa, the Group usesits expertise, infrastructure and scale benefits to transform its clients'services, driving down costs and adding value. Capita is quoted on the LondonStock Exchange (CPI.L), and is a constituent of the FTSE 100 with 2013 revenueof £3.9 billion. Further information on Capita plc can be found at:www.capita.co.uk Capita works with healthcare organisations to transform services, deliveringchange that supports high quality care and a positive patient experience whilesimultaneously achieving efficiency improvements across the organisation. Itprovides insight, advisory, infrastructure, performance and technology servicesto more than 400 healthcare organisations. Working in partnerships to drive improvements on the front-line, raise patientsafety standards and build integrated and sustainable health services, Capitahas helped providers and commissioners make step changes in performance overthe last 25 years. For more information about Capita's work in Health, pleasevisit: www.capitahealthpartners.co.uk
Date   Source Headline
1st Jun 20262:10 pmMFNCapita: Total Voting Rights
29th May 20264:40 pmMFNCapita: Director/PDMR Shareholding
29th May 20268:30 amMFNCapita: Director/PDMR Shareholding
26th May 20265:15 pmMFNCapita: Director/PDMR Shareholding
20th May 20269:15 amMFNCapita: Director/PDMR Shareholding
19th May 202612:40 pmMFNCapita: Correction - Announcement of Annual General Meeting Results
19th May 20268:00 amMFNCapita: Result of AGM
18th May 20269:00 amMFNCapita: Director/PDMR Shareholding
18th May 20267:00 amMFNCapita: Trading Statement
18th May 20267:00 amMFNCapita: Directorate change
13th May 20264:25 pmMFNCapita: Holding(s) in Company
12th May 202612:00 pmMFNCapita: Holding(s) in Company
11th May 202611:20 amMFNCapita: Holding(s) in Company
8th May 20263:15 pmMFNCapita: Director/PDMR Shareholding
5th May 20263:00 pmMFNCapita: Director/PDMR Shareholding
1st May 20268:00 amMFNCapita: Total Voting Rights
28th Apr 20262:00 pmMFNCapita: Directorate changes and withdrawal of AGM Resolution
9th Apr 20262:45 pmMFNDirector/PDMR Shareholding
9th Apr 202610:00 amMFNDirector/PDMR Shareholding
8th Apr 20261:00 pmMFNTotal Voting Rights and Capital
2nd Apr 20262:00 pmMFNDirector/PDMR Shareholding
2nd Apr 20268:30 amMFNIssue of new ordinary shares to satisfy share awards
1st Apr 20269:00 amMFNTotal Voting Rights
31st Mar 20264:05 pmMFNNotice of 2026 Annual General Meeting and publication of the Company’s 2025 Annual Report and Accounts
30th Mar 20267:30 amMFNDirector/PDMR Shareholding
26th Mar 20267:00 amMFNDisposal
24th Mar 20265:45 pmMFNDirector/PDMR Shareholding
24th Mar 20265:15 pmMFNDirector/PDMR Shareholding
24th Mar 202610:15 amMFNHolding(s) in Company
19th Mar 20268:40 amMFNDirector/PDMR Shareholding
18th Mar 20265:30 pmMFNDirector/PDMR Shareholding
18th Mar 20268:30 amMFNHolding(s) in Company
16th Mar 20269:50 amRNSDirector/PDMR Shareholding
16th Mar 20269:50 amMFNDirector/PDMR Shareholding
13th Mar 20269:30 amRNSHolding(s) in Company
13th Mar 20269:30 amMFNHolding(s) in Company
12th Mar 20263:20 pmMFNHolding(s) in Company
12th Mar 20263:15 pmMFNDirector/PDMR Shareholding
12th Mar 202611:40 amRNSHolding(s) in Company
12th Mar 202611:40 amMFNHolding(s) in Company
12th Mar 202611:10 amRNSDirector/PDMR Shareholding
12th Mar 202611:10 amMFNDirector/PDMR Shareholding
12th Mar 20269:00 amRNSDirector/PDMR Shareholding
12th Mar 20269:00 amMFNDirector/PDMR Shareholding
11th Mar 202611:56 amMFNDirector/PDMR Shareholding
11th Mar 20269:30 amRNSDirector/PDMR Shareholding
11th Mar 20269:30 amMFNDirector/PDMR Shareholding
11th Mar 20267:03 amRNSResponse to Ofgem statement regarding final price disallowance
11th Mar 20267:00 amRNSOfgem final decision on DCC cost allowances
10th Mar 20264:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.